Macrophage colony stimulating factor involvement in uremic patients

Kidney International

Volumn 50, Issue 3, 1996, Pages 1007-1012

  Le Meur, Yannick ^b   Fixe, Philippe ^b   Aldigier, Jean Claude ^b   Leroux Robert, Claude ^b   Praloran, Vincent ^a  

^a FR 3503 GEIST EA 1069 Laboratoire de Chimie des Substances Naturelles GDR CNRS 3049 Faculte de Ph   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

COLONY STIMULATING FACTOR 1; ERYTHROPOIETIN;

ADULT; AGED; ANEMIA; ARTICLE; CHRONIC KIDNEY FAILURE; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; CONTROLLED STUDY; FEMALE; HEMODIALYSIS; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; UREMIA;

EID: 0029742962     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1038/ki.1996.402     Document Type: Article

References (41)

1. GOLDBLUM S, REED W: Host defenses and immunologic alterations associated with chronic hemodialysis. Ann Inter Med 93:597-613, 1980
2. KHAN I, CATTO G: Long-term complications of dialysis: Infection. Kidney Int 43(Suppl 41):S143-S148, 1993
3. LINDNER A, FAREWELL V, SHERRARD D: High incidence of neoplasia in uremic patients receiving long-term dialysis. Nephron 27:292-296, 1981
4. LEWIS S, VAN EPPS D: Neutrophil and monocyte alteration in chronic dialysis patients. Am J Kidney Dis 5:381-395, 1987
5. DESCAMPS-LATSCHA B, HERBELIN A: Long-term dialysis and cellular immunity: A critical survey. Kidney Int 43(Suppl 41):S135-S142, 1993
6. VANHOLDER R, RINGOIR S, DHONDT A, HAKIM R: Phagocytosis in uremic and hemodialysis patients: A prospective and cross sectional study. Kidney Int 39:321-327, 1991
7. DONATI D, DEGIANNIS D, HOMER L, GASTALDI L, RASKOVA J, RASKA K: Immune deficiency in uremia: Interleukin-2 production and responsiveness and interleukin-2 receptor expression and release. Nephron 58:268-275, 1991
8. RASKOVA J, GHOBRIAL I, SCHEA S, EISINGER R, RASKA K: Suppressor cells in end-stage renal disease. Am J Med 76:847-853, 1984
9. DUMANN H, MEUER S, KÖHLER H: Uremic serum inhibits monocyte-dependent, but not interleukin-2 dependent step of T cell proliferation. Nephron 56:162-165, 1990
10. DONATI D, DEGIANNIS D, RASKOVA J, RASKA K: Uremic serum effects on peripheral blood mononuclear cell and purified T lymphocyte responses. Kidney Int 42:681-689, 1992
11. BEAURAIN G, NARET C, MARCON L, GRATEAU G, DRUEKE T, URENA P, NELSON D, BACH J-F, CHATENOUD L: In vivo T cell preactivation in chronic uremic hemodialyzed and not-hemodialyzed patients. Kidney Int 36:636-644, 1989
12. DESCAMPS-LATSCHA B, HERBELIN A, NGUYEN A, ROUX-LOMBARD P, ZINGRAFF J, MOYNOT A, VERGER C, DAHMANE D, DE GROOTE D, JUNGERS P, DAYER JM: Balance between IL-1β, TNF-α, and their inhibitors in chronic renal failure in maintenance dialysis. J Immunol 154:882-892, 1995
13. CHATENOUD L, JUNGERS P, DESCAMPS-LATSCHA B: Immunological considerations of the uremic and dialyzed patient. Kidney Int 45(Suppl 44):S92-S96, 1994
14. PRALORAN V: Structure, biosynthesis and biological roles of monocyte-macrophage colony stimulating factor. Nouv Rev Fr Hematol 33:323-333, 1991
15. HAMILTON J: Colony stimulating factors, cytokines and monocyte-macrophages some contreversies, Immunol Today 14:18-24, 1993
16. PRALORAN V, GASCAN H, PAPIN S, CHAVALIER S, TROSSAERT M, BOURSIER MC: Inductible production of Macrophage Colony Stimulating Factor by malignant and normal T cells. Leukemia 4:411-414, 1990
17. REISBACH G, SINDERMANN J, KREMER JP, HÜLTNER L, WOLF H, DÖRMER P: Macrophage Colony Stimulating Factor (CSF-1) is expressed by spontaneously outgrown EBV-B cell lines and activated normal B lymphocytes. Blood 74:959-964, 1989
18. FIXE P, LORGEOT V, LE MEUR Y, COUPEY L, HEYMANN D, GODARD A, PRALORAN V: Development of enzymo-immunoassays (EIA) for Macrophage Colony-Stimulating-Factor (M-CSF) and Leukemia Inhibitory Factor (LIF) by using the same capture and signal generating polyclonal antibody. Cytokine (in press)
19. PRALORAN V, COUPEY L, DONNARD M, BERRADA L, NAUD MF: Elevation of M-CSF concentrations during pregnancy and ovarian hyperstimulation. Br J Haematol 86:675-677, 1994
20. TANG R, BEUVON F, OJEDA M, MOSSERI V, POUILLART P, SCHOLL S: M-CSF and M-CSF receptor expression by breast tumor cells. J Cell Biochem 50:350-356, 1992
21. GILBERT HS, PRALORAN V, STANLEY ER: Increased circulating CSF-1 (M-CSF) in myeloproliferative disease: Association with myeloid metaplasia and peripheral bone marrow extension. Blood 74:1231-1234, 1989
22. STANLEY ER, BERG KL, EINSTEIN DB, LEE PSW, YEUNG, YG: The biology and action of Colony Stimulating Factor-1. Stem Cells 12(Suppl 1):15-25, 1994
23. KAWANO Y, TAKAUE Y, MOTOYOSHI K MINAKUCHI J, SAITO S, HIRAO A, SATO J, SHIMIZU T, KUDURA Y: Measurement of serum levels of macrophage colony-stimulating factor (M-CSF) in patients with uremia. Exp Hematol 21:220-222, 1993
24. SATO H, OHKUBO M, NAGAOKA T: Levels of serum colony-stimulating factor in patients in long term haemodialysis. Cytokine 2:187-194, 1994
25. PRALORAN V, LE MEUR Y, COUPEY L: Increased levels of serum macrophage colony stimulating factor in patients with chronic renal insufficiency: Facts and hypotheses. Cytokine 7:221-222, 1995
26. BARTOCCI A, MASTROGIANNIS DS, MIGLIORATI G, STOCKERT RJ, WOLKOFF AW, STANLEY ER: Macrophages specifically regulate the concentration of their own growth factor in the circulation. Proc Natl Acad Sci USA 84:6179-6183, 1987
27. PRALORAN V, RAVENTOS-SUARES C, BARTOCCI A, LUCAS J, STANLEY ER, GIBBONS JJ JR: Alterations in the expression of colony stimulating factor 1 and its receptor during an acute graft vs host reaction in mice. J Immunol 145:3256-3261, 1990
28. MOTOYOSHI K, TAKAKU F, MIZOGUCHI H, MIURA Y: Purification and some properties of colony stimulating factor from normal human urine. Blood 52:1012-1020, 1978
29. DAS SK, STANLEY ER, GUILBERT LJ, FORMAN CW: Human colony stimulating factor radioimmunoassay: Resolution of three subclasses of human colony stimulating factors. Blood 58:630-641, 1981
30. SHIEH JH, PETERSON R, WARREN D, MOORE M: Modulation of colony stimulating factor-1 receptors on macrophages by tumor necrosis factor. J Immunol 143:2534-2539, 1989
31. GUILBERT LJ, STANLEY ER: Modulation of receptors for the colony stimulating factor, CSF-1, by bacterial lipopolysaccharide and CSF-1. J Immunol Meth 73:17, 1984
32. LONNEMAN G, BINGEL M, FEOEGE J, KOCH K, SHALDON S, DINARELLO C: Detection of cndotoxin-like interleukin-1-inducing activity during in vitro dialysis. Kidney Int 33:29-35, 1988
33. PEIREIRA B, SNODGRASS B, HOGAN P, KING A: Diffusive and convectivc transfer of cytokine-inducing bacterial products across hemodialysis membranes. Kidney Int 47:603-610, 1995
34. BETZ, M, HAENSCH G, RAUTERBERG E, BOMMER J, RITZ E: Cuprammonium membranes stimulate interleukin-1 release and arachidonic acid metabolism in monocytes in the absence of complement. Kidney Int 34:67-73, 1988
35. GODAI K, UEMASU J, KAWASAKI H: Clinical significance of serum and urinary neopterins in patients with chronic renal disease. Clin Nephrol 36:141-146, 1991
36. HERBELIN A, URENA P, NGUYEN AT, ZINGRAFF J, DESCAMPS-LATSCHA B: Influence of first and long term dialysis on uremia-associated increased basal production of Interleukin-1 and tumor necrosis factor a by circulating monocytes. Nephrol Dial Transplant 6:349-357, 1991
37. PERTOSA G, GESUALDO L, TARANTINO E, RANIERI E, BOTTALICO D, SCHENA F: Influence of hemodialysis on interleukin-6 production and gene expression by peripheral blood mononuclear cells. Kidney Int 43(Suppl 39):S149-S153, 1993
38. URENA P, GOGUSEV J, VALDIVONOS R, HERBELIN A, DRUEKE T: Transcriptional induction of TNF α in uremic patients undergoing hemodialysis. (abstract) J Am Soc Nephrol 1:380, 1990
39. ULICH R, DEL CASTILLO J, WATSON L, YIN S, GARNICK M: In vivo hematologic effects of recombinant human macrophage colony-stimulating factor. Blood 75:846-850, 1990
40. MUNN DH, GARNICK MB, CHEUNG NKV: Effects of parenteral recombinant human macrophage colony stimulating factor on monocyte number, phenotype and antitumor cytotoxicity in non human primate. Blood 75:2042-2048, 1990
41. CASSIDY M, DE JAGER C, EBRAHIM O, CAMACHIO P, ROBSON S: Peripheral blood mononuclear cells from patients with chronic renal failure release factors which supress crythropoietin in vitro. Nephrol Dial Transplant 9:775-779, 1994